Lisa A. Newman, MD, MPH
AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship

Lisa A. Newman, MD, MPH

Chief, Division of Breast Surgery
Director, Interdisciplinary Breast Program
Medical Director, International Center for the Study of Breast Cancer Subtypes
Weill Cornell Medical Center
New York, New York

For her significant contributions to the identification of biomarkers for triple-negative breast cancer in African American and African women, and her dedication to mentoring students and trainees from groups traditionally underrepresented in medicine and research.

The AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship was first presented in 2006. The lectureship is intended to recognize an outstanding scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of minority investigators in cancer research.

Newman is a world-renowned expert in breast surgical oncology whose exceptional body of research has significantly advanced the understanding of breast cancer risk and clinical outcomes in African and African American women. To investigate the heterogeneity of breast cancer subtypes and to better understand the complex role of race and ethnicity in breast cancer risk, Newman formed an international collaboration with physicians and researchers in Ethiopia, Ghana, Nigeria, Uganda, Canada, and the Caribbean. Earlier in her research career, she conducted a seminal meta-analysis of more than 10,000 African American patients and 40,000 white American patients with breast cancer, discovering that African American ethnicity is an independent predictor of poor prognosis. Building on this research, Newman and colleagues worked to improve the Gail Breast Cancer Risk Assessment tool to better assess risk among African American women. Through further population-based studies, Newman identified substantial evidence for higher rates of advanced-stage TNBC in young African American women compared to white American women ages 40-49 or older. Newman’s recent work has identified additional biomarkers for breast cancer in African American women, most recently in a study where African Americans were found to have higher proportions of DARC/ACKR1 negative tumors compared to white women. To learn more, please visit the press release.

View Past Recipients